Double board-certified facial plastic surgeon Dr. Shervin Naderi has been recognized as one of America’s Best Rhinoplasty Plastic Surgeons by Newsweek in 2023.

WASHINGTON (PRWEB)
August 11, 2023

Dr. Shervin Naderi was distinguished in the rhinoplasty category in Newsweek’s prestigious second annual ranking of the country’s top plastic surgeons. He was recognized for his artistic mastery, innovative techniques, and commitment to patient satisfaction at The Naderi Center, which has two locations in the Greater Washington DC metro with offices in Reston Virginia, and Chevy Chase Maryland.

As a preeminent rhinoplasty expert, Dr. Naderi combines his extensive experience and perceptive eye to craft elegant, natural-looking results tailored to each patient. Unlike any other Plastic Surgeon in the United States, Dr. Naderi exclusively performs only one surgery – Rhinoplasty, making him a true Rhinoplasty specialist.

A Prestigious Honor Among the Nation’s Best

Earning a spot on Newsweek’s selective list is an exceptional achievement that denotes superior expertise and patient satisfaction. The America’s Best Plastic Surgeons ranking is based on a rigorous selection process involving thousands of medical professional recommendations and assessments of quality of care.

Out of about 12,000 plastic surgeons only 358 plastic surgeons across 20 states made the final list this year, which speaks to the highly competitive nature of this honor. Dr. Naderi was one of only 165 honored for rhinoplasty surgery.

This prestigious accolade affirms Dr. Naderi’s leading reputation and validates the consistently outstanding care he provides patients. His position among the top plastic surgeons world wide underscores Dr. Naderi’s commitment to achieving beautiful, natural, harmonious results and the highest levels of patient satisfaction through his rhinoplasty practice.

About Dr. Shervin Naderi

Dr. Shervin Naderi is renowned as an exceptional rhinoplasty surgeon and a leading authority on nasal surgery. Although The Naderi Center provides a full array of face and body cosmetic surgery procedures with several ultra specialist surgeons, Dr. Naderi is focused on the nose.

Almost a quarter century ago, after completing his residency in Head and Neck Surgery at Indiana University School of Medicine, Dr. Naderi pursued an intensive fellowship under world-renowned facial plastic surgeon Dr. Stephen Perkins. This advanced training allowed him to hone his skills and develop techniques to expertly handle the intricacies of nasal surgery. He has grown exponentially and innovated far more superior techniques since then.

With over two decades of experience performing thousands of rhinoplasties, Dr. Naderi has become one of the most sought-after rhinoplasty surgeons in the world. He is able to precisely diagnose structural issues and create customized surgical plans to optimize both form and function. A Naderi Nose is uniquely tailored for each patient with no cookie cutter noses and no telltale signs of plastic surgery.

His accomplishments and reputation for excellence have earned Dr. Naderi international recognition. Patients come from all over the United States and overseas for the opportunity to have their surgery performed by Dr. Naderi.

Dr. Naderi’s Prestigious Accolades and Accomplishments

Dr. Shervin Naderi has received numerous honors and distinctions that underscore his leading reputation as an elite rhinoplasty surgeon, including:

• 
  Double board certification in Facial Plastic & Reconstructive Surgery and Otolaryngology – Head & Neck Surgery
• Named one of America’s Best Plastic Surgeons by Newsweek (2023)
• Recognized as a Top Beauty Doctor (2016)
• Awarded the RealSelf 500 Award (2015)
• Selected as one of Virginia’s Favorite Physicians by Vitals Patients’ Choice Award (2016)
• Chosen as the Most Compassionate Doctor by his patients (2011)
• Voted the #1 Top Rated Cosmetic Surgeon in Washington, DC
• Listed in the Global Directory of Who’s Who
• Named an Outstanding Cosmetic Surgeon by the National Institute of Cosmetic And Plastic Surgery Research

Dr. Naderi’s extensive expertise and commitment to patient satisfaction have earned him a reputation as one of the country’s foremost rhinoplasty experts. But his reputation for honesty and ethics is truly unique in a profession often known for too many sales pitches. Dr. Naderi spends many hours each week talking potential patients out of cosmetic surgery.

A Personalized Approach to Facial Harmony

During consultations, Dr. Naderi conducts a detailed assessment of the entire facial structure. He takes the time to understand his patients’ specific goals and address any concerns they may have. With this understanding, professional insight, and experience, Dr. Naderi crafts personalized surgical plans that aim to create a natural-looking nose, perfectly complementing the individual’s facial features.

Dr. Nader’s patients have the opportunity to see advanced computer imaging to demonstrate the potential outcome of their surgery.

In certain cases, Dr. Naderi may advise patients that rhinoplasty is unnecessary or recommend alternative treatments better suited to their objectives. Patient education and satisfaction take precedence over any other incentives.

Dr. Naderi’s thorough, honest communication and mastery of facial aesthetics have earned the trust of his patients. His focus remains on fulfilling their goals and creating a nose they will feel proud of for a lifetime.

About The Naderi Center

The Naderi Center was founded by Double Board Certified Facial Plastic Surgeon, Dr. Shervin Naderi who is an expert in revision rhinoplasty and rhinoplasty surgery. Patients from around the world seek his expertise. The Naderi Center for Plastic Surgery & Dermatology and Dr. Shervin Naderi have been featured in numerous media publications such as the Northern Virginia Magazine, New Beauty Magazine, Capital Files Magazine, Washingtonian Magazine, DC Magazine and Bethesda Magazine, among many others.

If you are interested in learning more about the services offered at The Naderi Center or would like to schedule a consultation with double board certified facial plastic surgeon, Dr. Naderi or one of the other ultra specialist plastic surgeons there please call 703-481-0002 or 301-222-2020 to set up a consultation at the Reston or Chevy Chase office.

Share article on social media or email:

CDI Week 2023

“Each year it’s our pleasure to recognize CDI professionals during this special week of festivities. We can never say enough about the essential work CDI professionals tirelessly contribute to improve documentation and patient care for healthcare organizations.” — Rebecca Hendren

BRENTWOOD, Tenn. (PRWEB)
August 11, 2023

The Association of Clinical Documentation Integrity Specialists (ACDIS) presents CDI Week, September 18–22, 2023. This annual week of recognition celebrates the clinical documentation integrity (CDI) profession with a series of complimentary learning opportunities and discounts. This year’s offerings include a free webinar, daily Q&As from the Furthering Education Committee, giveaways, and a deep dive into the state of the industry.

The theme for this year is “CDI success stories: Writing your next chapter!” While the career story of a CDI professional can be rather open-ended, ACDIS wants to focus on how its members can make the most of those blank pages and write the success they want to see, no matter if they area CDI specialist, educator, leader, physician advisor, or HIM professional.

“In many ways, this profession is like an unfinished book, with so much of its future unknown,” said Rebecca Hendren, ACDIS director of programming. “But it can be exciting to not have everything written out for you! Maybe you’ll write a new specialty or position into your next chapter or branch out your story into a whole new setting. The beautiful thing is that CDI professionals have the chance to decide for themselves and author their own careers.”

In conjunction with CDI Week, ACDIS has conducted its 13th annual CDI Industry Survey. This year’s survey examines topics such as provider engagement, professional development and staffing, outpatient CDI and risk adjustment, denial trends and CDI involvement, and workflow tools and technology. With the support of CDI Week’s partners 3M Health Information Systems and Nuance, ACDIS will conduct daily interviews with industry experts and post the interviews on the association’s website.

More information about CDI Week offerings and activities can be found at https://acdis.org/cdi-week.

ACDIS also provides year-round professional development opportunities, including:

###

About ACDIS

ACDIS has 6,700 members and more than 40 local chapters and networking groups dedicated to the CDI profession. As the premier healthcare community of CDI professionals, the Association shares the latest tips, tools, and strategies to implement successful CDI programs. ACDIS also provides continuing education, certifications, training, networking events, CDI resources, and opportunities for professional growth. Learn more at https://acdis.org/.

About HCPro

For over 34 years, HCPro, a division of Simplify Compliance LLC, has specialized in providing the latest healthcare regulatory information through industry-leading publications, continuing education, online coding platforms, instructor-led training, events, consulting services, and more to deliver consistent training, achieve compliance, and maximize workflow efficiencies, resulting in measurable performance and financial improvements. Visit http://www.hcpro.com/.

Share article on social media or email:

Pulse Engagement Cloud + Google Analytics 4

“With the launch of GA4, our life science clients will have a deeper understanding of how their audience is engaging and with what content.” said Ryan Alovis, Chief Executive Officer of Pulse Health.

GARDEN CITY, N.Y. (PRWEB)
August 11, 2023

Pulse Health, a leading provider of cloud-based technology and services for the life science industry, announced that it has completed its integration of Google Analytics 4 (GA4) within the Pulse Engagement Cloud. This feature is immediately available to all customers.

Pulse Health’s Google Analytics 4 Integration will give users a more complete way to understand the impact of the brand’s non-personal messaging to its healthcare professionals, allowing deeper insight and visibility into visitor interactions. The GA4 plugin reinforces Pulse Health’s overall commitment to providing its clients with the most robust offering of integrations, whether pharma focused or generalized technologies.

“With the launch of GA4, our life science clients will have a deeper understanding of how their audience is engaging and with what content. As always, we’ll continue powering their HCP messaging via email, SMS, banners, all while providing even more visibility to their overall traffic data.” said Ryan Alovis, Chief Executive Officer of Pulse Health. “There is a CRM blind spot when it comes to the emerging biotech, or small to mid-size pharma companies, and we want them to know that we’re purpose built to help them grow.”

Widely known as the only life science focused omnichannel platform that offers an emphasis on NPI-driven integrations, quality HCP and patient data, all with built-in customer support to assist in executing and monitoring campaigns. The platform has a proven track record of upping script lift, most recently finalizing a third-party impact review, showing Pulse was responsible for yielding a 15% lift in scripts written for one of their brands. Pulse Health is committed to bringing effective solutions to an industry that is plagued with inefficiencies ranging from disparate data sources to the reliance of multiple single-feature industry generic platforms, absentee client support, or the inability to access actionable data in real-time.

In addition to the GA4 integration, Pulse Health has recently announced its integration with Smarty Streets, enabling its pharma partners to validate over 160 million USPS addresses plus over 15 million non-postal addresses. By offering Smarty Streets via the Pulse Engagement Cloud, customers can have access to real-time hygiene to maintain the highest quality database and optimization of tactic delivery.

For more information on how Pulse Health is powering digital engagement for the life science industry, visit https://pulsehealth.tech/

About Pulse Health

Pulse Health is an industry leader in cloud-based non-personal promotional engagement software and services for the life science industry. Powering a brands journey from launch to life. Pulse Health’s suite of products range from Pulse Engagement Cloud, Pulse Sample Management, Pulse HCP & Patient Data Access, Pulse Insights, and Pulse MCM Tactics. Pulse Health’s client base range from emerging biotech bringing their brands to commercialization, to global pharmaceutical companies looking to amplify their existing brands.

Share article on social media or email:

Pam Cheng

NORTH BETHESDA, Md. (PRWEB)
August 11, 2023

The International Society for Pharmaceutical Engineering (ISPE) announced eight keynote speakers for the 2023 ISPE Annual Meeting & Expo, occurring 15-18 October in Las Vegas, NV, and virtually. This acclaimed event brings together top pharmaceutical industry and regulatory leaders, offering compelling presentations and interactive discussions on industry-critical technical developments.

The 2023 ISPE Annual Meeting & Expo features a dynamic line-up of thought-provoking keynote presentations led by some of the most prominent names in the pharmaceutical industry.

Confirmed Keynote Speakers:

Pam Cheng – Executive Vice President, Global Operations and Information Technology – AstraZeneca

Pam Cheng is the Executive Vice President, Global Operations and Information Technology, and Chief Sustainability Officer for AstraZeneca. She led AstraZeneca’s Global Operations in developing and supplying 3 billion COVID-19 vaccine doses to more than 170 countries. With oversight across 18 countries, Pam manages manufacturing, supply chain, procurement, IT, and sustainability, leading a team of over 20,000. Prior, she spent 18 years at Merck/MSD in global roles. Pam holds bachelor’s and master’s degrees in chemical engineering from Stevens Institute of Technology and an MBA in marketing from Pace University.

Judy Chou – President and CEO – AltruBio, Inc

Judy Chou, PhD is the CEO, President, and board member of AltruBio, Inc., a clinical-stage biotech company in San Francisco, CA. With a remarkable career in the biomedical industry, she has led global biotech organizations, including Bayer Pharmaceuticals. Judy’s expertise lies in the development and manufacturing of biologics, and she has made significant contributions to breakthrough technologies and accelerated product development. She serves on the boards of Akero Therapeutics, Inc., California Institute of Regenerative Medicines (CIRM), and advisory boards for UC Berkeley Engineering School and Silicon Valley Women in Engineering.

David Churchward – Global Head Sterility Assurance, Cell and Gene Technologies – Lonza Biologics

David Churchward is the Global Head of Sterility Assurance for Lonza Biologics’ cell and gene technologies business unit. With extensive experience in regulatory collaboration and international harmonization, David ensures sterility assurance standards for manufacturing cell therapies and viral vector products. He previously served as a GMP inspector with the UK MHRA and contributed to major regulatory initiatives.

Kyle Haraldsen – Chief Technology Officer – Lyndra Therapeutics

Kyle Haraldsen is the Chief Technology Officer of Lyndra Therapeutics. With over 20 years of industry experience, he leads product and platform R&D activities, including the development of the LYNX™ drug delivery platform. Kyle has a strong background in technical operations, product development, and project management, having held leadership positions at Saniona and AMAG Pharmaceuticals.

Celia Lourenco – Acting Associate Assistant Deputy Minister – Health Canada

Celia Lourenco, PhD, is the Acting Associate Assistant Deputy Minister for the Health Products and Food Branch of Health Canada. With extensive experience in drug regulation, Celia provides strategic direction for health product and food regulation. She has engaged with international regulatory authorities and co-chaired the COVID-19 working group at the International Coalition of Medicines Regulatory Authorities.

Flavius Martin – Executive Vice President of Research – Gilead Sciences, Inc

Flavius Martin is the Executive Vice President of Research at Gilead Sciences, Inc. In this role, he oversees innovative research and preclinical programs across therapeutic areas. With nearly 20 years in the biopharmaceutical industry, Flavius has held leadership positions at Amgen and Genentech, contributing to advancements in oncology, inflammation, and cardiometabolic research.

Matthew Pearl – Patient Advocate – Fanconi Anemia Research Fund & EveryLife Foundation

Matthew Pearl is a remarkable patient advocate and a dedicated contributor to various nonprofits who captivates audiences worldwide, sharing his invaluable insights and inspiring the Rare Disease Community. His commitment extends to organizations such as the Fanconi Anemia Research Fund, the Rare Action Network, the National Organization for Rare Disorders, and the National Ability Center. Matthew’s groundbreaking research at the Dana Farber Cancer Institute at Harvard, where he was the first Fanconi Anemia (FA) patient to investigate FA, has garnered international recognition.

Michael Lee Sherwood – Chief Innovation and Technology Officer – City of Las Vegas

Michael Lee Sherwood has over 20 years of experience in process improvement, technology, and innovation. As the Chief Innovation and Technology Officer for the City of Las Vegas, he drives initiatives to create brighter and more sustainable communities through collaboration and workforce development. Michael previously served as the Deputy Director of Public Safety, Business Services & City Technology for the City of Irvine, California.

Learn more and register for the 2023 ISPE Annual Meeting & Expo today.

About ISPE

The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.

Share article on social media or email:

David J. Galas, Ph.D.

“WRF’s generous gift is a profound testament to David, who never stopped discovering and pushed the boundaries of our knowledge about genetics right up to the end of his life.” Diane Isonaka

SEATTLE (PRWEB)
August 10, 2023

Washington Research Foundation (WRF) has awarded a $100,000 grant to Pacific Northwest Research Institute (PNRI) in honor of David J. Galas, Ph.D., who helped to create the WRF Postdoctoral Fellowship program in 2017 and served on the WRF board of directors from 2010 until his death in May. The grant will support the continuation of work begun by Galas and his colleague Lisa Stubbs, Ph.D., investigating the genetic links between stress and a range of health disorders.

Galas was a renowned expert in molecular biology and human genetics. He was a leader in the Human Genome Project and a key contributor to the technology that enabled one of the earliest rapid tests for COVID-19. In 2012, he joined PNRI as a senior investigator.

Inspired to apply his novel computational approaches to find ways to improve the human condition, Galas, together with PNRI senior investigator Stubbs, launched the groundbreaking Decoding Stress Study in 2021. The goal of the study is to pinpoint the exact genes, gene networks and patterns of mutations responsible for how humans’ brains and bodies respond to chronic stress and to identify how an individual’s unique genetic makeup contributes to their risk of developing stress-related diseases, such as anxiety, depression, type 2 diabetes and heart disease.

Galas and his team focused on developing and applying innovative mathematical methods, providing new computational tools to seek out and validate genetic interactions significant to this research. The findings of the Decoding Stress Study will ultimately provide the basis for new genetic screens to identify people who are at the greatest risk of developing stress-related disease, as well as to guide doctors in choosing the right treatment for each person.

With support from WRF’s grant, Stubbs will continue to lead this project.

“We are honored to continue pursuing David’s vision—that of using an individual’s unique genetic make-up to identify those at greatest risk of stress-related diseases—with the goal of developing tailored therapies to identify and treat them. This is David’s legacy gift to all humanity,” said Stubbs.

In addition to his roles with PNRI and WRF, Galas was chair of the Hertz Foundation board of directors, a lifetime National Associate of the National Academy of Sciences, and an entrepreneur who held 20 issued U.S. patents and authored more than 180 scientific publications. He was also an accomplished artist and poet.

Brooks Simpson, WRF’s board chair, said, “David was an incredible board member and mentor to all of us. We are better board members, stronger staff and an enriched organization because of him. As an example, David’s insight and belief in postdocs led to the creation of our fellowship program. That will always remain a hallmark of our contributions to the research engines in the region.”

“WRF’s generous gift is a profound testament to David, who never stopped discovering and pushed the boundaries of our knowledge about genetics right up to the end of his life,” said Diane Isonaka, Galas’ widow. “This gift will ensure that the innovative methods and tools that David introduced in the Decoding Stress Study will continue to shape the field of genetics and benefit generations to come with improved healthcare, personalized treatments and a deeper understanding of life itself.”

###

About Pacific Northwest Research Institute:

Pacific Northwest Research Institute (PNRI) is a nonprofit biomedical research institute, where scientists use innovative approaches in genetics and genomics to tackle some of the most difficult problems in science and medicine. The institute was founded 67 years ago in Seattle, Washington, as a place where scientists were free to pursue discoveries that promised the highest chance of improving human health. The goal was at the beginning, and remains today, to conduct foundational science that drives future medical innovations. To learn more, visit pnri.org.

About Washington Research Foundation:

Washington Research Foundation (WRF) supports research and scholarship in Washington state, with a focus on life sciences and enabling technologies. WRF was founded in 1981 to assist universities and other nonprofit research institutions in Washington with the commercialization and licensing of their technologies. WRF is one of the foremost technology transfer and grant-making organizations in the nation, having earned more than $445 million in licensing revenue for the University of Washington and providing over $147 million in grants to the state’s research institutions to date.

WRF Capital, the investment vehicle for Washington Research Foundation, has backed 122 local startups since 1996. Returns support the Foundation’s investment and grant-making programs.

For additional information, please visit wrfseattle.org.

Share article on social media or email: